Ksenia A. Kazakova

Ksenia A. Kazakova

Auto-generated profile, based on publicly available information

Ksenia A. Kazakova

Multi-profile medical holding SM-Clinic

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Russian Annals of Ophthalmology
Verified
Journal Article
Closed access
MFM. A. Frolov
M. A. Frolov
AFA. M. Frolov
A. M. Frolov
KKK. A. Kazakova
K. A. Kazakova

13 November 2021 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
VBV. A. Biletskaya
V. A. Biletskaya
DLDmitry Valentinovich Lipatov
Dmitry Valentinovich Lipatov
MFM. A. Frolov
M. A. Frolov
KKK. A. Kazakova
K. A. Kazakova
Today, diabetes is one of the leading medical and social problems. This is due to a pandemic increase in the development of the disease. Eye complications that occur against the background of diabetes are complex. Diabetic damage to the visual organ is the main cause of visual acuity in these patients. One of the serious complications of proliferative diabetic retinopathy is secondary neovascular glaucoma, which is often refractory to treatment and eventually leads to irreversible blindness. Currently, neovascular glaucoma is an important and urgent problem in modern society, as it leads a large number of patients to disability and impaired social adaptation. The paper presents a review of the literature on the current state of the problem of neovascular glaucoma and presents the results of major international studies.Based on the data of domestic and foreign literature, the authors provide up-to-date information on the incidence, evaluate the clinical manifestations of the disease, paying attention to new methods of diagnosis and treatment. These data allow us to evaluate the effectiveness of modern therapeutic and surgical approaches in the treatment of neovascular glaucoma, as well as its various complications and measures for their prevention.

15 December 2011
Verified
Journal Article
Closed access
MFM A Frolov
M A Frolov
PGP A Gonchar
P A Gonchar
VBV I Barashkov
V I Barashkov
VKVinod Kumar
Vinod Kumar
NMN S Morozova
N S Morozova
KKK A Kazakova
K A Kazakova

7 August 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
MFM. A. Frolov
M. A. Frolov
NSN. A. Sakhovskaya
N. A. Sakhovskaya
KKK. A. Kazakova
K. A. Kazakova
VLV. S. Luchin
V. S. Luchin
TGT. I. Gavrilenko
T. I. Gavrilenko
Introduction. According to ophthalmologists, the number of patients with signs of asthenia and asthenopia has increased substantially over the past few years. It is a known fact that good nutrition, adequate intake of vitamins and minerals with diet, compliance with work-rest regime is a necessary condition for the prevention and elimination of clinical presentations of these pathologies.Aim. To assess the results of the use of biologically active food additives Doppelherz® Kinder Omega-3 for children from 7 years old and Doppelgerz® Kinder multivitamins for children in paediatric population with signs of asthenia and asthenopia.Materials and methods. A total of 90 children aged 7-12 years with signs of reactive asthenia and asthenopia were included in the study. Patients in group 1 received the biologically active food additive Doppelherz® Kinder Omega-3 for children from 7 years old; patients in group 2 – Doppelgerz® Kinder multivitamins for children; patients in group 3 – did not receive any biologically active food additives or vitamins.Results. The CISS questionnaire showed a reduction in the severity of signs of asthenopia in group 1, less pronounced reduction of signs in group 2, and insignificant reduction in group 3. The Swanson scale showed a decrease in the degree of inattention in group 1, a decrease in the degree of inattention and impulsivity in group 2. I.K. Shats questionnaire showed that asthenia decreased from severe to moderate in group 1, and from severe to a fatigue reaction in group 2. In all groups that complied with the general recommendations, an increase in the relative accommodation reserve was observed. Evidence from pupillography indicates decreased accommodation tension, which was more pronounced in group 2 as compared with group 1, and insignificant in group 3. The Norn test and the tear meniscus height values confirmed an improvement in the tear film status, which was more pronounced in group 1 than in group 2.Discussion. There are three main directions of the treatment strategy for asthenia: etiopathogenetic, nonspecific and symptomatic therapy. Targeted addition of vitamin and mineral complexes to a child’s diet is a reasonable and integral part of the pathogenetic treatment of asthenia and asthenopia.Conclusion. A decrease in signs of asthenopia, improvement of the tear film state, reduction in signs of inattention due to increased concentration, and improvement of memory was observed in the group of patients who used the biologically active food additives with omega-3 for children from 7 years old, as compared to the control group. A decrease in signs of asthenia, and improvement of the tear film state was observed in the group of patients who used multivitamins for children — chew strips with raspberry flavour.

26 March 2022 in Russian Ophthalmological Journal
Verified
Journal Article
Open access
PDF file
MFM. A. Frolov
M. A. Frolov
KKK. A. Kazakova
K. A. Kazakova
NSN. A. Sakhovskaya
N. A. Sakhovskaya
VLV. S. Luchin
V. S. Luchin
Purpose: to assess the effect of the biologically active additive complexes “Doppelherz® active Vitamins for eyes with lutein” and “Doppelherz® active Vitamins for eyes with chromium, zinc and selenium” on the functional state of the eye in patients with chronic ischemic optic neuropathy (ION).Material and methods. The study involved 60 patients (111 eyes) aged 51–92 (ave. 62.2 ± 1.2 yrs) with chronic ION divided into three groups of 20 patients each. Group I received the first additive, “Doppelherz® active Vitamins for eyes with lutein”; Group II received the second additive, “Doppelherz® active Vitamins for eyes with chromium, zinc and selenium”; and Group III receive no additives at all. The additives were taken according to the standard scheme — 1 tab per os during the first meal for 2 months. All patients were examined before the start and 2 months hereafter.Results. A positive trend in best corrected visual activity (BCVA) were noted in groups I and II. Group I showed an increase in the critical flicker frequency (CFF) of the red and blue spectra by 1.06 and 1.33 %, respectively, a decrease in the green spectrum by 2.7 % (p < 0.05), and an improvement in the visual fields by 0.61 %. Group II demonstrated an increase in the CFF of the red spectrum by 1.2 %, green — by 2.7 %, blue — by 0.8 %, and an improvement in visual fields by 3.08 %. Group III showed a negative trend in visual functions: BCVA dropped by 1.92 %, and CFF decreased in the green and blue spectra by 3.34 % (p < 0.05) and 0.1 %, respectively. Retinal photosensitivity improved in group I by 0.31 %, in group II by 0.59 % (p < 0.05), in group III it dropped by 0.56 %. A survey showed a decrease in asthenic and asthenopic complaints by patients of groups I and II.Conclusion. A positive effect of both biologically active additive complexes on the functional state of the eye has been revealed.

24 August 2020 in Ophthalmology Reports
Verified
Journal Article
Open access
PDF file
NSNatalya A. Sakhovskaya
Natalya A. Sakhovskaya
MFMichael A. Frolov
Michael A. Frolov
KKKsenia A. Kazakova
Ksenia A. Kazakova
EBElena S. Belyaeva
Elena S. Belyaeva
САСаховская Наталья Анатольевна
Саховская Наталья Анатольевна
The outcome of any damage or disease of the optic nerve is the atrophy of the optic nerve, which causes the irreversible loss of vision. The reasons of damage of the optic nerve are polymorphous, and early diagnosis allows to improve the efficacy of treatment and prevent irreversible consequences. The article presents a difficult clinical case of optic neuropathy differential diagnosis.